Hugo Van Heuverswyn

BioMARIC is a fully privately owned Belgian biotechnology company founded in 2001, which is predominantly focusing on prevention and control of infectious diseases. BioMARIC develops, manufactures, and distributes high-performance biomaterials and best-in-class multi-analyte in vitro diagnostic devices (CE-IVD and RUO) for the detection of human infectious pathogens in blood bank screening such as HIV, HCV, HTLV as well as for travel-associated infections such as Chikungunya, dengue, West Nile, Yellow Fever, Zika, SARS viruses. In the same field BioMARIC is finalizing the development of an innovative digital multi-analyte rapid-test platform, suitable for bedside- and home testing. In addition to its IVD program, BioMARIC is also investing in the in-house development of a needle-free oral vaccination platform particularly suitable for mass vaccination in the LMI countries